
11BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US2561352038
CUSIP
256135203
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
36.69
PEG Ratio
1.57
Book Value
0.82
Dividend Share
8
Dividend Yield
0.63%
Earnings Share
0.36
Wall Street Target Price
13.82
EPS Estimate Current Year
56.33
EPS Estimate Next Year
51.82
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
329,843,015,680
Gross Profit TTM
163,241,000,960
EBITDA
49,928,998,912
Profit Margin
8.49%
Return On Assets TTM
3.38%
Return On Equity TTM
7.34%
Revenue Per Share TTM
66.1477
Qtly Revenue Growth YOY
-1.50%
Diluted Eps TTM
0.36
Qtly Earnings Growth YOY
-35.70%
Trailing PE
36.69
Forward PE
25
Price Sales TTM
0.0334
Price Book MRQ
2.4589
Enterprise Value Revenue
2
Enterprise Value EBITDA
14
239.95
3.94%99.09
1.98%40.44
1.46%32.14
0.19%161.82
0.04%12.25
0.00%41.22
0.00%10.08
-1.17%20.28
-0.76%46.10
-0.43%